We also observed a similar level of liver hypertrophy and liver steatosis in LKO mice treated with AAV-AMPK-DN compared to FF mice (Fig. 6k, l and Supplementary Fig. 6f). Here, PRKAA2 is linked to Hepatic steatosis.